For the quarter ending 2026-02-28, CBIH made $11,205 in revenue. -$103,933 in net income. Net profit margin of -927.56%.
| Income Statement | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 |
|---|---|---|---|---|
| Revenues | 11,205 | 53,266 | 24,200 | -76,680.5* |
| Cost of revenues | 3,045 | 10,500 | 8,143 | 15,858.5* |
| Gross profit | 8,160 | 42,766 | 16,057 | -92,539* |
| General and administrative | 26,828 | 30,972 | 23,308 | -50,230* |
| Contract labor | 37,865 | 36,141 | 42,520 | 25,166.5* |
| Professional fees | 13,185 | 52,035 | 7,741 | 101,614* |
| Officer compensation | 11,089 | 8,094 | 6,000 | 6,000* |
| Share-based compensation | - | - | 0 | - |
| Rent and lease | 11,469 | 11,339 | 11,059 | 10,270.5* |
| Travel | 983 | 62 | 213 | 158.5* |
| Total operating expenses | 101,419 | 138,643 | 90,841 | 92,979.5* |
| Operating loss | -93,259 | -95,877 | -74,784 | -185,518.5* |
| Amortization of discount | 0 | 0 | 19,815 | 11,038.5* |
| Note discount expense | 0 | 3,230 | - | -33,600* |
| Forgiveness of debt | 0 | 0 | 0 | -47,276* |
| Change in fair value of derivative liabilities | 0 | 0 | 29,322 | 7,330.75* |
| Interest | 10,776 | 17,860 | 17,368 | 112,168.25* |
| Other income/loss | 101 | - | - | - |
| Total other income (expense) | -10,675 | -21,090 | -7,861 | -129,552* |
| Net loss | -103,933 | -116,966 | -82,645 | -315,070.5 |
| Basic EPS | -0 | -0 | -0 | -0 |
| Diluted EPS | -0 | -0 | -0 | -0 |
| Basic Average Shares | 11,626,749,347 | 11,626,749,347 | 11,626,749,347 | 11,192,673,271 |
| Diluted Average Shares | 11,626,749,347 | 11,626,749,347 | 11,626,749,347 | 11,192,673,271 |
Cannabis Bioscience International Holdings, Inc. (CBIH)
Cannabis Bioscience International Holdings, Inc. (CBIH)